corneal new vessels can result in significant loss of vision as well as reduce graft survival. Recently, newer treatment modalities have been introduced. however, attempts to meet the challenge of evaluating corneal vessels by quantification are evolving. In vivo evaluations range from computer-aided analysis of colour images to determination of area, diameter and tortuousity of blood vessels on indocyanine green angiography images. attempts at developing a fully automated process of evaluation and quantification are hampered by the anatomical variations of limbus, random nature of blood vessels and multiple levels of involvement of the corneal stroma. currently, semi-automated methods require manually fixing the limbus prior to quantification of vessels. using indocyanine green angiography, the full extent of corneal vessels even in the presence of scarring can be determined. With the evolution of new techniques, it is hoped that a robust corneal vessel quantifying tool will be described in the near future that will aid the effectiveness of treatment strategies.
success in addition to the side effects. as the molecular mechanisms of angiogenesis are being better understood and with the advent of antiangiogenic treatments for exudative age-related macular degeneration, the prospect for corneal new vessel management looks brighter. Vascular endothelial growth factor (VEGF) inhibitors, by targeting the angiogenic process at a molecular level can limit or cause regression of corneal NVs with minimal side effects. a recent meta-analysis found that both topical and subconjunctival bevacizumab achieved significant reduction in the area of corneal NVs. 15 With the introduction of new treatment modalities comes the challenge of evaluation of effectiveness. accurate comparison requires adequate quantification of corneal blood vessels.
In Vitro Corneal New Vessel Imaging
Several animal studies have described different in vitro methods of quantification that have been insufficiently validated. Proia et al. used india ink enhancement of blood vessels on histological samples. 16 later, immunofluorescent staining of vascular endothelial cells was utilised to quantify corneal NVs on animal models. 17, 18 While these experimental in vitro animal models have broadened our understanding of the pathology, they are of little assistance in the day-to-day management of a patient with corneal NVs.
In Vivo Corneal New Vessel Imaging
The simplest method of documenting corneal NVs is colour-coded drawings. an easily adaptable quantification process of corneal nvs in a clinical scenario was described by pillai et al. 13 they evaluated nvs in terms of the number of quadrants involved, the depth of vessels and whether they were active or quiescent. no details of how the differentiation between activity and quiescence was made are provided. vassilev also described a similar method of quantification by analysing corneal photographs and determining the number, size and centricity of vessels.
this analysis was performed by the same non-blinded reviewer. 24 lai et al. described a grading system of corneal nvs. 25 they graded nvs as mild when cornea showed one to six vertical neovascularisation areas, moderate where there are more than 15 vertical vessels and none.
there was, however, no standardisation of vertical vessels and hence was prone to subjective interpretations. importantly, these clinical grading systems may not take into account blood vessels obscured by corneal scar tissue.
Semi-automated Evaluation of Corneal New Vessels
the development of computer software technology led to the evolution of computer-aided methods of quantification of corneal nvs at the turn of the century. computer-aided semi-automated approaches of analysing retinal blood vessels have been described before. 26 while the latter had better reproducibility compared with clinicians, quality of images, pupil size, density of scar and poorly defined limbus as in vascularisation affected the ability of the software program to perform the analysis. Small vessels were also not detected by the software due to the minimal pixel difference.
another approach to a semi-automated method of corneal nvs was described by otoum and Edirisinghe 32 utilising the contourlet transform
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EuropEan ophthalmic rEviEw principle that takes into account the shape of cornea. their technique involves manually fixing a limbus on a digital colour image followed by contrast enhancement, noise removal, segmentation of blood vessels and determination of the total area occupied by the blood vessels by pixel counting.
these early attempts at devising a semi-automatic method for corneal nvs quantification have the potential to be a useful aid in clinical practice to monitor response to treatments. a major drawback of these methods is that there is an underestimation of the nvs in presence of scarring as we have shown in our study. Fossarello et al. described using fluorescein and indocyanine green angiography (icGa) to describe the regressive effects of corneal nvs treated with pDt. 35 there was no attempt at quantification. we have described a technique of documenting corneal nvs using Fa and icGa. 33 after obtaining digital photographs using standard settings, intravenous indocyanine dye was injected into a peripheral vein as for retinal angiography. Single-frame icGa photographs were taken every 3 to 5
(now every second) seconds for 3 minutes utilising a scanning laser ophthalmoscope (hra2; heidelberg Engineering, heidelberg, Germany).
the process was repeated after injecting intravenous fluorescein.
compared with clinical, colour and Fa images, icGa showed welldelineated vessels even in the presence of scarring (see Figure 2 and 3) .
the fluorescence in Fa was partially blocked in presence of scarring (see Figure 3) . also, the leakage of fluorescein obscured vessel details.
indocyanine dye being more protein bound is better retained in blood vessels compared with fluorescein dye. therefore, we used icGa images for describing vessel parameters. the area of corneal nvs and geometric properties (length, diameter and tortuosity) were determined using a computer program written in numerical computing language (matlab r14; the math works inc., natick, massachusetts).
the process involved defining the limbus manually, followed by estimation of pixel resolution.
the corneal vessels were defined manually and enhanced through a Gaussian filter to remove noise, followed by application of selective enhancement filters as originally described by li et al. 36 37 Stereo images of corneal icGa have the capability of indicating depth of nvs (see Figure 4) . though invasive, with a small possibility of allergic reactions, icGa-aided quantification of corneal nvs has the potential to be a robust research tool.
Confocal Evaluation of Corneal New Vessels
confocal imaging of cornea in health and disease has evolved in the last decade although there is a paucity of studies describing corneal blood vessels. this could be due to the technical and interpretation corneal blood vessel imaging has evolved significantly from descriptive analysis of colour photographs to computer-aided quantification methods.
no single method has emerged as a useful clinical or research tool so far. the 3D shape of cornea and multilevel distribution of blood vessels in the stroma in a random manner makes evaluation of vasculature difficult. to overcome these limitations, we are developing use of stereophotographs allowing measurement of vessels in different planes. n
